Dermatology News & Information
Upcoming Events
New Faculty Spotlights
Instructor
Being an instructor at YSM is a unique and fulfilling experience for me because it allows me to combine my passion for research and clinical work. The environment at YSM encourages innovation and collaboration, which is vital for someone like me. It's an institution where I can actively contribute to the advancement of medical knowledge. My role at YSM primarily involves research and building up my clinical practice.
In the coming year, I aspire to further my research into the potential link between immune checkpoints and hidradenitis suppurativa, which could lead to significant advancements in the field. The inspiration to pursue this area of interest comes from the profound impact it has on the quality of life of those who suffer from it. The possibility of discovering a link to immune checkpoints is particularly exciting, as it could offer new treatment options and insights into the pathophysiology of the disease. This motivates me to delve deeper into my research and contribute to improving the lives of individuals affected by this condition.
In my free time, I'm an avid fitness enthusiast, and I enjoy working out to stay healthy and maintain a balanced lifestyle. I also find solace in tending to my garden and watching it flourish and thrive as I care for it. Playing with my kids is another source of joy for me, as their laughter provides a refreshing break from the demands of my profession. These interests and hobbies help me maintain a well-rounded life, balancing the demands of academia, research, and clinical practice.
Assistant Professor in Dermatology
My primary passion is as a clinician taking care of patients, and I see a wide variety of medical and general dermatology in my practice at Yale Dermatology New Haven and at Yale Health. I have a particular interest in women's health/dermatology, especially dermatology as it relates to pregnancy and lactation, and I hope to grow my practice in this area.
In addition to my clinical work, I greatly enjoy my involvement in medical education, and I participate in teaching residents, medical students, and PA students. I particularly enjoy working with residents at the Cornell Scott Hill Health dermatology clinic. Ultimately, my primary goal is always to be the type of doctor that I would want to have myself, and to give each patient an individualized, thoughtful approach to their care. Yale Dermatology is a special place to practice because of the expertise, resources, and research that we have at our fingertips. It allows me to offer the best care to my patients.
I live on the Shoreline with my husband (a Yale radiation oncologist) and one-year-old son, and I enjoy hiking, baking, and spending time with family.
Publications
- Machine learning analysis of pretreatment skin biopsies predicts nonresponse to dupilumab in patients with eczematous dermatitisMurphy M, Hwang E, Singh K, Lee T, Cohen J, Damsky W. Machine learning analysis of pretreatment skin biopsies predicts nonresponse to dupilumab in patients with eczematous dermatitis. British Journal Of Dermatology 2023, 190: 132-134. PMID: 37818837, DOI: 10.1093/bjd/ljad389.
- Treatment options for necrobiosis lipoidica: a systematic reviewNihal A, Caplan A, Rosenbach M, Damsky W, Mangold A, Shields B. Treatment options for necrobiosis lipoidica: a systematic review. International Journal Of Dermatology 2023, 62: 1529-1537. PMID: 37772666, DOI: 10.1111/ijd.16856.
- 43437 Ustekinumab for the Treatment of Metastatic Crohn DiseaseMcKay G, Coromilas A, Liu L, Murphy M, Punyamurthy N, Damsky W, Wanat K, Rosenbach M, Caplan A, LaSenna C, Shields B. 43437 Ustekinumab for the Treatment of Metastatic Crohn Disease. Journal Of The American Academy Of Dermatology 2023, 89: ab103. DOI: 10.1016/j.jaad.2023.07.414.
- 44140 Obsessive-Compulsive Disorder Among Patients with Atopic Dermatitis: A Case-Control Study in the All of Us Research ProgramChen G, Fan R, Leasure A, Damsky W, Cohen J. 44140 Obsessive-Compulsive Disorder Among Patients with Atopic Dermatitis: A Case-Control Study in the All of Us Research Program. Journal Of The American Academy Of Dermatology 2023, 89: ab69. DOI: 10.1016/j.jaad.2023.07.279.
- 44291 Population-level data reveals prognostic factors and contextualizes outcomes of malignant blue nevusMirza F, Yumeen S, Mirza H, Zogg C, Leventhal J, Cohen J. 44291 Population-level data reveals prognostic factors and contextualizes outcomes of malignant blue nevus. Journal Of The American Academy Of Dermatology 2023, 89: ab208. DOI: 10.1016/j.jaad.2023.07.835.
Article Spotlight
News
Dr. Richard Edelson on Yale Cancer Answers
Dr. Richard Edelson on Yale Cancer Answers.
16 Oct 2023Woman's Colleague Spots Mark on Her Arm That Led to Cancer Diagnosis
A rise in melanoma cases in recent years has led the American Cancer Society to estimate that approximately 97,610 new cases will be diagnosed in 2023, resulting in 7,990 deaths. Although the average age to receive a diagnosis is 65, melanoma can occur at any age and is prevalent in young females. Fortunately, there are ways to reduce the risk of melanoma or to catch it early. Dr. Jonathan Leventhal, the director of the Onco-Dermatology Program at Smilow Cancer Hospital and Yale Cancer Center said that UV exposure is the primary risk of skin cancer, so the importance of sun safety shouldn't be underestimated. "UV exposure is the greatest environmental risk factor, so prevention includes avoiding UV damage to the skin," Leventhal told Newsweek. "Avoid tanning beds, protect skin outdoors by seeking shade, wear protective clothing, hat, and sunglasses, apply broad-spectrum sunscreen SPF 30 or above, and reapply frequently.
Source: Newsweek14 Oct 2023First Cancer Moonshot Award Announced at Yale School of Medicine
Yale School of Medicine and Congresswoman Rosa DeLauro announced the first Advanced Research Projects Agency for Health (ARPA-H) grant in the United States, which is an outgrowth of President Biden's Cancer Moonshot program.
29 Sep 2023National Medical Fellowships Diversity in Clinical Trials Research Program Admits William D. Shipman, MD, PhD
William D. Shipman, MD, PhD, a PGY-4 resident and postdoctoral fellow in the Department of Dermatology, joins the fall cohort of the National Medical Fellowships Diversity in Clinical Trials Research Program. The purpose of the Program is to train and diversify clinical trial Principal Investigators, thereby increasing the diversity among trial participants and generating a more inclusive and comprehensive body of research data.
13 Nov 2023Do you put sunscreen on your ears? 5 areas you probably miss when applying an SPF
Sunscreen is essential to your skincare routine - whether you're 15 or 50, you should apply a good SPF daily to protect yourself from harsh UV rays.
Source: News2424 Oct 2023Skin in the game
Skin in the game: A physician-scientist's passions
1 Nov 2023Yale scientists chosen by White House to expedite cancer research
Yale is one of three institutions that have been honored with the White House Cancer Moonshot research grant. Yale's Douglas Hanlon, PhD, research scientist in dermatology, and Richard Edelson, MD, the Anthony N. Brady Professor of Dermatology, describe their groundbreaking research, using mRNA technology to create a vaccine that targets only cancer cells.
Source: WTNH News 817 Nov 2023